PG
NXTM

PEAK6 Group’s NxStage Medical Inc. NXTM Stock Holding History

PEAK6 Group’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,800
Closed -$82K – 4963
2016
Q2 		$82K Buy
+3,800
New +$67.8K ﹤0.01% 3672
2016
Q1 		– Sell
-20,000
Closed -$438K – 5359
2015
Q4 		$438K Buy
20,000
+17,800
+809% +$332K ﹤0.01% 2713
2015
Q3 		$35K Buy
+2,200
New +$35.3K ﹤0.01% 4761
2013
Q3 		– Sell
-20,500
Closed -$293 – 5697
2013
Q2 		$293 Buy
+20,500
New +$258K ﹤0.01% 3295

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

PEAK6 Group's NXTM Position: Q2 2018 in Review

PEAK6 Group reduced its NxStage Medical Inc. (NXTM) stake by 20% in Q2 2018, selling an estimated $402K and leaving 60,000 shares worth $1.67M. The position accounts for 0.01% of the portfolio, ranked #1509.

PEAK6 Group first reported a position in NXTM in Q2 2013 and has held it in 11 quarters since. The position peaked at $1.87M in Q3 2017. 171 funds tracked by Wall St. Rank hold NXTM as of Q2 2018.

  • PEAK6 Group held 60,000 shares of NxStage Medical Inc. worth $1.67M as of Q2 2018.
  • PEAK6 Group sold 15,000 NxStage Medical Inc. shares in Q2 2018, an estimated $402K.
  • NxStage Medical Inc. made up 0.01% of PEAK6 Group's portfolio in Q2 2018, its #1509 holding.
  • PEAK6 Group first reported a position in NxStage Medical Inc. in Q2 2013 and has held it in 11 quarters since.
  • PEAK6 Group's NxStage Medical Inc. position peaked at $1.87M in Q3 2017.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.